Homing agents
US-9849201-B2 · Dec 26, 2017 · US
US11052163B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11052163-B2 |
| Application number | US-201715711780-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 21, 2017 |
| Priority date | May 3, 2013 |
| Publication date | Jul 6, 2021 |
| Grant date | Jul 6, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides peptide constructs for diagnostic imaging and therapeutic applications, using pegylated peptides which exhibit specific binding for a target molecule of interest, such as a biomarker of a disease or disorder.
Opening claim text (preview).
What is claimed is: 1. A p-armed multimer, wherein p is 4 and each arm of the multimer comprises: a polymer comprising n PEG monomers, wherein n is 9; a homing molecule that is SEQ ID NO: 1; a chelating agent that is N2S2; and a linker consisting of glutamic acid; wherein the polymer, the homing molecule and the chelating agent are each attached to the linker and wherein at least one of the polymer, the homing molecule or the chelating agent is attached to a side chain of an amino acid in the linker; and wherein each arm of the multimer is bound to the other arms of the multimer via an end of the polymer not attached to the linker. 2. A p-armed multimer of claim 1 , wherein the amino acid side chain is directly attached to one of the polymer, homing molecule or chelating agent. 3. A p-armed multimer of claim 1 , wherein the amino acid side chain is attached via click chemistry to one of the polymer, homing molecule or chelating agent. 4. A p-armed multimer of claim 1 , wherein the homing molecule is linked to the C-terminus of glutamic acid, and the polymer is linked via an amino acid side chain of glutamic acid. 5. A p-armed multimer of claim 1 , further comprising a radionuclide bonded to the chelating agent on at least one arm. 6. A p-armed multimer of claim 5 , further comprising a radionuclide bonded to the chelating agent on at least one arm. 7. A radiopharmaceutical composition comprising a p-armed multimer of claim 5 , together with a pharmaceutically-acceptable carrier. 8. A p-armed multimer of claim 1 , wherein the homing molecule is attached to the linker via a hydrophilic moiety. 9. A method for detecting intradevice thrombus in a subject having an implanted mechanical circulation assist device, the method comprising: (a) administering into the bloodstream of the subject an effective amount of a p-armed multimer of claim 5 ; (b) allowing the p-armed multimer to bind thrombus; and (c) detecting a signal from the radionuclide of the p-armed multimer localized at a site of thrombus. 10. The method of claim 9 , wherein the method further comprises quantifying intradevice thrombus by: (d) determining the amount of p-armed multimer localized at a site of thrombus from the signal detected, wherein the amount of p-armed multimer is indicative of the size of the thrombus.
conjugated systems · CPC title
having 5 to 11 amino acids · CPC title
Methine dyes, e.g. cyanine dyes · CPC title
conjugates with carriers being macromolecules · CPC title
conjugates with carriers being peptides, polyamino acids or proteins (antibodies A61K51/10) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.